throbber
CFAD V. Anacor, IPR2015-01776, CFAD EXHIBIT 1054 - Page 1 of 22
`
`CFAD v. Anacor, IPR2015-01776, CFAD EXHIBIT 1054 - Page 1 of 22
`
`

`
`BIOLOGICAL TRACE ELEMENT RESEARCHi--
`
`Published under the auspices of the International Association of Bioinorganic Scientists
`Official Journal of the World Biomedical Selenium Society
`Gerhard N. Schrauzer • Editor-in-Chief
`Biological Trace Element Research Institute • San Diego, CA
`Manuel F. Flores-Arce• Managing Editor
`Laboratory of Trace Elements and Environmental Toxicology, Instituto Tecnologico de Tijuana, Mexico
`Charles H. Hill• Editor• College of Agriculture and Life Sciences• North Carolina State University •
`Raleigh •NC 27695
`..
`Peter Schramel• Editor, Trace Element Analysis • Institut fur Okologische Chemie • GfS, Ingolstadter
`Lanstrasse #1 • D-8402 Neuherberg, Germany
`Yasushi Kodama• Editor• School of Medicine• University of Environmental and Occupational Health•
`Iseigaoka Yahata Nishi Ku • Kitakyushu, Japan 807
`Alain Favier • Editor • Laboratoire de Biochemie C, CHU de Grenoble, Hopital A. Michallon, BP 217,
`38043 Grenobole, France
`
`T. Akiyama, University of Occupational
`and Environmental Health, Kitakyushu, Japan
`J. A. Centeno, AFIP, Washington, DC
`G. F. Combs, Jr., Cornell University, Ithaca, NY
`M. Costa, New York University Medical Center, NY, NY
`R. J. Cousins, University of Florida, Gainesville, FL
`U. M. Cowgill, Carbondale, CO
`A. T. Diplock, Guy's Hospital Medical School, London, UK
`Jose L. Domingo, Universitat Rovira i Virgili, Reus, Spain
`I.E. Dreosti, CSIRO, Adelaide, Australia
`' L. Flohe, GBF, Braunschweig, Germany
`A. Furst, University of San Francisco, San Francisco, CA
`E. Harper, University ofCalifomia, San Diego, La Jolla, CA
`. R. I. Henki.n, Georgetown University Hospital,
`Washington, DC

`V. Iyengar, NIST, Gaithersburg, MD
`T. Jukes, University of California, Berkeley, CA
`M. Krachler, Research Center of Jiilich, Jiilich, Germany
`P. Laszlo, University de Liege, Liege, Belgium
`B. Liinnerdal, University of California, Davis, CA
`C. J. Lovatt, University ofCalifomia. Riverside, CA
`
`Editorial Board
`E. J. Massaro, Duke University, Durham, NC
`D. M. Medeiros, Ohio State University, Columbus, OH
`F. H. Nielsen, USDA ARS, Grand Forks, ND
`R. Osterberg, Swedish University of Agricultural
`Sciences, Uppsala, Sweden
`W. Pories, East Carolina School of Medicine,
`Greenville, NC
`P. D. Saltman, University of California, La Jolla, CA
`H. H. Sandstead, University of Texas, Galveston, TX
`B. Sarkar, Hospital for Sick Children, Toronto, Canada
`J.E. Spallholz, Texas Tech University, Lubbock, TX
`F. W. Sunderman, Jr., University of Connecticut
`Medical School, Farmington, CT
`G-q. Wang, Xi'a)l Medical University,
`Xi'an Shaanxi, PROC
`P. D. Whanger, Oregon State Univ., Corvallis, OR
`D.R. Williams, University of Wales, Cardiff, Wales, UK
`G. Yamada, Kumamoto University, Kumamoto, Japan
`P. F. Zatta, CNR Center, University of Padova, Italy
`A. Zgirsky, University of Lodz, Poland
`
`Volume 66, Numbers 1-3, Winter 1998
`Copyright © 1998 Humana Press Inc. All Rights Reserved.
`
`This publication is printed on acid-free paper.@)
`ANSI Z39 .48-1984 (American National Standards Institute) Permanence of Paper for Printed Library Materials.
`
`No part of this publication may be reproduced or transmitted in any form or by any means, electronic or
`mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in
`writing from the copyright owner. All authored papers, editorials, news, comments, opinions, conclusions, or
`recommendations are those of the author(s), and do not necessarily reflect the views of the publisher.
`
`Biological Trace Element Research is made available for abstracting or indexing in Chemical Abstracts,
`Current Contents, Index Medicus, Excerpta Medica, Biological Abstracts, Science Citation Index, and
`appropriate related compendia.
`
`Subscription Information: Biological Trace Element Research (ISSN 0163-4984) is published 18 times per year
`(monthly+ two extra volumes) in six volumes. Subscription price for Vols. 61-66 is $775 (US) and $825 (foreign); please add
`$40 (US) or $60 (foreign) for postage.
`POSTMASTER: Send address changes to Biological Trace Element Research. Humana Press, 999 Riverview Dr., Suite
`208, Totowa, NJ 07512. All correspondence, subscription orders, and notices of change of address (both old and new addresses
`must be provided) should be sent at least 8 weeks in advance of the date of effect to Humana Press. Periodicals postage is paid
`at Passaic, NJ, and at additional mailing offices, by the Humana Press.
`Photocopy Authorization Policy: Authorization to photocopy items for internal or personal use, or the internal or personal
`use of specific clients, is granted by Humana Press, provided that the base fee of US $8.00 per copy, plus US $00.25 per page,
`is paid directly to the Copyright Clearance Center Inc, 222 Rosewood Drive, Danvers, MA 01923. For those organizations that
`been granted a photocopy license from the CCC, a separate system of payment has been arranged and is acceptable to
`ana Press. The fee code for users of the Transactional Reporting Service is: 0163-4984/98 $8.00 + $00.25.
`
`CFAD v. Anacor, IPR2015-01776, CFAD EXHIBIT 1054 - Page 2 of 22
`
`

`
`Biological Trace Element Research
`
`Vol. 66, Nos. 1-3, Winter 1998
`
`Proceedings of the Second International Symposium
`
`on the Health Effects of
`
`Boron
`and Its Compounds
`
`October 22-24, 1997
`
`GUEST EDITORS
`
`B. DWIGHT CULVER
`FRANK M. SULLIVAN
`
`F. JAY MURRAY
`}AMES R. COUGHLIN
`PHILIP L. STRONG
`
`CFAD v. Anacor, IPR2015-01776, CFAD EXHIBIT 1054 - Page 3 of 22
`
`

`
`Biological Trace Element Research
`
`Vol. 66, Nos. 1-3, Winter 1998
`
`CONTENTS
`
`Second International Symposium on the Health Effects of Boron and Its Compounds:
`Introduction
`B. Dwight Culver ...................................................................................................................... 1
`
`Considerations in the Determination of Boron at Low Concentrations
`R. Gregory Downing,* Philip L. Strong, B. Michael Hovanec, and
`Jack Northington ................................................................................................................ 3
`
`A Round-Robin Determination of Boron in Botanical and Biological Samples
`R. Gregory Downing* and Philip L. Strong ...................................................................... 23
`
`Isotope Ratio Determination in Boron Analysis
`Ram N. Sah* and Patrick H. Brown ................................................................................... 39
`
`Measurement of Borate in Occupational Environments
`Robert A. Smith* and Frederick M. Ascher[ ...................................................................... 55
`
`A Comparison of Worker Exposure to Inhalable and Total Dust, Inorganic Arsenic,
`and Borates Using Tw:i Types of Particulate Sampling Assemblies in a Borate
`Mining and Processing Facility
`M.A. Katchen, * V. A. Puhalovich, R. Swaroop, and B. D. Culver .............................. 59
`
`Dietary Boron Intakes of Selected Populations in the United States
`Susan L. Meacham* and Curtiss D. Hunt .......................................................................... 65
`
`Multicountry Estimation of Dietary Boron Intake
`Charlene Rainey* and Leslie Nyquist ................................................................................ 79
`. Sources of Human Exposure: Overview of Water Supplies as Sources of Boron
`fames R. Coughlin ................................................................................................................... 87
`
`In Vivo Percutaneous Absorbtion of Boron as Boric Acid, Borax, and Disodiurn
`Octaborate Tetrahydrate in Humans: A Summary
`Ronald C. Wester,* Xiaoying Hui, Howard I. Maibach, Kathleen Bell,
`Michael J. Schell, D. Jack Northington, Philip L. Strong,
`and B. Dwight Culver ..................................................................................................... 101
`
`In Vitro Percutaneous Absorbtion of Boron as Boric Acid, Borax, and Disodiurn
`Octaborate Tetrahydrate in Human Skin: A Summary
`Ronald C. Wester,* Tracy Hartway, Howard I. Maibach, Michael/. Schell,
`D. f ack Northington, B. Dwight Culver, and Philip L. Strong ............................. 111
`
`Boron Exposure from Consumer Products
`Margaret Richold .................................................................................................................. 121
`
`Distribution of Boron in the Environment
`Peter Argust ........................................................................................................................... 131
`
`The Isotopic Composition of Anthropogenic Boron and Its Potential Impact
`on the Environment
`Avner Vengosh ....................................................................................................................... 145
`
`A Review of Boron Effects in the Environment
`Paul D. Howe ......................................................................................................................... 153
`
`*For papers with multiple authorship,the asterisk identifies the author to \-\horn correspondence
`and reprint requests should be addressed.
`
`CFAD v. Anacor, IPR2015-01776, CFAD EXHIBIT 1054 - Page 4 of 22
`
`

`
`Biological Trace Element Research
`
`Vol. 66, Nos. 1-3, Winter 1998
`
`CONTENTS
`
`Relationships Betw=en Boron Concentrations and Trout in the Firehole River,
`Wyoming: Historical Information and Preliminary Results of a Field Study
`foseph S. Meyer,* Ann M. Boelter, Daniel F. Woodward, f ack N. Goldstein,
`Ai"da M. Farag, and Wayne A. Hubert···························································~············· 167
`
`Review of the Scientific Basis for Establishing the Essentiality of Trace Elements
`Walter Mertz .......................................................................................................................... 185
`
`Determining Human Dietary Requirements for Boron
`Barbara Sutherland,* Phil Strong, and fanet C. King .................................................. 193
`Regulation of Enzymatic Activity: One Possible Role of Dietary Boron in Higher
`Animals and Humans
`Curtiss D. Hunt ..................................................................................................................... 205
`
`The Nutritional and Metabolic Effects of Boron in Humans and Animals
`S. Samman, * M. R. Naghii, P. M. Lyons Wall, and A. P. Verus ................................. 227
`
`Adverse Reproductive and Developmental Effects in Xenopus from
`Insufficient Boron
`Douglas f. Fort,* Timothy L. Propst, Enos L. Stover, Philip L. Strong,
`and F. fay Murray ............................................................................................................ 237
`
`The Response of Trout and Zebrafish Embryos to Low and High Boron
`Concentrations Is U-Shaped
`Ruby l. Rowe, Collen Bouzan, Sam Nabili, and Curtis D. Eckhert* ......................... 261
`
`Assessing the Effects of Low Boron Diets on Embryonic and Fetal Development
`in Rodents Using In Vitro_an4 In Viv:o Model Systems
`Louise Lanoue, Marie W. Taubeneck; fesus Muniz, Lynn A. Hanna,
`Philip L. Strong, F. fay Murray, Forrest H. Nielsen, Curtiss D. Hunt,
`and Carl L. Keen* ............................................................................................................. 271
`
`The Importance of Boron Nutrition for Brain and Psychological Function
`fa mes G. Penland .................................................................................................................. 299
`
`The Justification for Providing Dietary Guidance for the Nutritional Intake of Boron
`Forrest H. Nielsen ................................................................................................................. 319
`
`A Comparative Review of the Pharmacokinetics of Boric Acid in Rodents
`and Humans
`F. Jay Murray ......................................................................................................................... 331
`
`Comparative Toxicology of Borates
`Susan A. Hubbard ................................................................................................................. 343
`
`Developmental Effects of Boric Acid in Rats Related to Maternal Blood Boron
`Concentrations
`Catherine f. Price,* Philip L. Strong,
`F. fay Murray, and Margaret M: Goldberg ................................................................ 359
`
`*For papers with multiple authorship,the asterisk identifies the author to -whom correspondence
`and reprint requests should be addressed.
`
`CFAD v. Anacor, IPR2015-01776, CFAD EXHIBIT 1054 - Page 5 of 22
`
`

`
`Biological Trace Element Research
`
`Vol. 66, Nos. 1-3, Winter 1998
`
`CONTENTS
`
`Effects of Boric Acid on Axial Skeletal Development in Rats
`Michael G. Narotsky, * fudith E. Schmid, fames E. Andrews,
`and Robert J. Kavlock .................................................................................................... 373
`
`The Effects of Dietary Boric Acid on Bone Strength in Rats
`Robert E. Chapin,* Warren W. Ku, Mary Alice Kenney, and Harriet McCoy ......... 395
`
`Comparison of Infertility Rates in Communities from Boron-Rich and
`Boron-Poor Territories
`E. Tiiccar, A.H. Elhan, * Y. Yavuz, and B. S. Sayli ....................................................... 401
`
`An Assessment of Fertility in Boron-Exposed Turkish Subpopulations:
`2. Evidence That Boron Has No Effect on Human Reproduction
`Bekir Sitki Sayli .................................................................................................................... 409
`
`The Effect of Essentiality on Risk Assessment
`George C. Becking ................................................................................................................. 423
`
`International Programme on Chemical Safety (IPCS) Environmental Health Criteria
`on Boron Human Health Risk Assessment
`George C. Becking* and Bing-Heng Chen ........................................................................ 439
`
`Boron Tolerable Intake: Re-evaluation of Toxicokinetics for Data-Derived
`Uncertainty Factors
`Michael Dourson, *Andrew Maier, Bette Meek, Andrew Renwick,
`Edward Ohanian, and Kenneth Poirier ...................................................................... 453
`
`Summary of Research Needs
`Frank M. Su.l!ivan_ a1J,d B. Dwight Culver* ................ .-............. :·~·······················--············· 4~5
`
`Author Index ....................................................................................................................... 469
`
`Subject Index ...................................................................................................................... .471
`
`"For papers with multiple authorship, the asterisk identifies the author to whom correspondence
`and reprint requests should be addressed.
`
`CFAD v. Anacor, IPR2015-01776, CFAD EXHIBIT 1054 - Page 6 of 22
`
`

`
`©Copyright 1998 by Humana Press Inc.
`All rights of any nature, whatsoever, reserved.
`0163-4984/98/6601-3--0001 $08.25
`
`Second International Symposium
`on the Health Effects of Boron
`and Its Compounds
`Introduction
`
`The Second International Symposium on the Health Effects of Boron
`and Its Compounds, October 22-24, 1997, brought together investigators
`interested in the effects of boron in biological and environmental systems
`at toxicological, pharmacological, and nutritional levels. A majority of
`the principal investigators working in these areas reported the results
`of the studies they have conducted over the past five years. Important
`contributions were made also by participants interested in the research
`methods required to measure these effects, especially at low-exposure
`levels where the complex chemistry of boron must be taken into account.
`Studies pointing to the nutritional importance of boron have been
`-conducted-over the past 20 years, and at the 1992 symposium, a number
`of studies investigating the nutritional role of boron were presented.
`However, it was not until this present symposium that the essentiality of
`boron for some vertebrate species was demonstrated.
`As was the case with the First International Symposium held in
`1992, it was hoped that this symposium would, by presenting as com(cid:173)
`pletely as possible the current state of knowledge about boron and its
`compounds, stimulate research into issues identified by the participants.
`The concluding article in this volume is an effort to underline future
`research needs.
`
`Biological Trace Element Research
`
`1
`
`Vol. 66, 1998
`
`CFAD v. Anacor, IPR2015-01776, CFAD EXHIBIT 1054 - Page 7 of 22
`
`

`
`©Copyright 1998 by Humana Press Inc.
`All rights of any nature, whatsoever, reserved.
`0163-4984/98/6601-3-0343 $11.75
`
`Comparative Toxicology of Borates
`SUSAN A. HUBBARD
`Borax Europe Limited, Guildford, GU2 5RQ, UK
`
`ABSTRACT
`
`Inorganic borates, including boric acid, Na, ammonium, K,
`and Zn borates generally display low acute toxicity orally, der(cid:173)
`mally, and by inhalation. They are either not irritant or mild skin
`and eye irritants. Exceptions owing to physiochemical properties
`do occur.
`Longer-term toxicological studies have been reported mainly on
`boric acid or borax where the properties are generally similar on an
`equivalent boron (B) basis. The critical effects in several species ·are
`male reproductive toxicity and developmental toxicity. The doses that
`cause these effects are far higher than any levels to which the human
`population could be exposed. Humans would need to consume daily
`some 3.3 g of boric acid (or 5.0 g borax)-to ingest the same dose level
`as the lowest animal NOAEL. No effects on fertility were seen in a
`population of workers exposed to borates or to a population exposed
`to high environmental borate levels.
`There is remarkable similarity in the toxicological effects of
`boric acid and borax across different species. Other inorganic borates
`that simply dissociate to boric acid are expected to display similar
`toxicity, whereas those that do not dissociate simply to boric acid
`may display a different toxicological profile.
`Index Entries: Borates; boric acid; borax; reproductive toxicity;
`developmental toxicity.
`
`INTRODUCTION
`
`A number of detailed reviews of the toxicology of borates have been
`published (1-5). The majority of toxicological studies of borates have
`involved either boric acid (H3B03) or disodium tetraborate decahydrate,
`known as borax (Na2B407'10H20). Studies of other inorganic borates,
`including Na tetraborates, octaborate, perborates, metaborates, and
`ammonium, K, and Zn borates have largely been confined to acute toxi(cid:173)
`cological studies. The inorganic borates that have been tested for acute
`
`Biological Trace Element Research
`
`343
`
`Vol 66, 1998
`
`CFAD v. Anacor, IPR2015-01776, CFAD EXHIBIT 1054 - Page 8 of 22
`
`

`
`344
`
`l
`
`I
`
`Hubbard
`
`Table 1
`Major Inorganic B Compounds and Their Oral LD50 Values
`LD50 mg/kg
`Reference
`rat
`
`Boric acid
`Boric oxide (anhydrous boric acid)
`
`Disodium tetraborate decahydrate (Borax)
`Disodium tctraborate pentahydrate
`Anhydrous disodium lelraborale
`
`Na2B.07 • 10Hp
`Na2B.O, •5H20
`Na2B40 7
`
`Disodium octaborate letrahydrate
`
`Sodium metaborale dihydrale
`Sodium metaborate tetrahydrate
`
`Disodium pcrborale tetrahydrate
`Disodium perborale monohydrate
`
`NaB02• 2H20
`NaB02• 4H20
`
`NaB0 3 •4H20
`NaB03. • H20
`
`2660- 4100
`> 2000
`
`4500- 6000
`3200- 3400
`> 2000
`
`2550
`
`> 2000
`2300
`
`21, 22
`24
`
`21
`23
`25
`
`30
`
`26
`27
`
`2100, 2243
`l 120- 2100
`
`32 reviewed
`in 2
`
`Diammonium tctraborale tetrahydrate
`Ammonium pentaborale tetrahydrale
`
`(Nl-l.JiB.O, • 4H20
`NH4B50 8 • 4H 20
`
`>4200 (mice)
`> 4200 (mice)
`
`Potassium tctraborale tclrahydrate
`
`K2B40 7 • 4H20
`
`3700
`
`Zinc borate 2.3.3.5
`Zinc borate 4.1.1
`
`2Zn0 • 3 8 20.i • 3.5 H20
`4Zn0 • 8 20 3 • H20
`
`> 10000
`>5000
`
`28
`28
`
`29
`
`31
`32
`
`toxicity are listed in Table 1. Only boric acid and borax fl.ave been evalu(cid:173)
`ated in longer-term studies.
`Most of these simple inorganic borates exist predominantly as undis(cid:173)
`sociated boric acid in dilute aqueous solution at physiological pH, lead(cid:173)
`ing to the conclusion that the main species in the plasma of mammals is
`likely to be undissociated boric acid. Differences in physiochemical prop(cid:173)
`erties may lead to other species existing in water, such as:
`1. The formation of hydrogen peroxide with Na perborate.
`2. The formation of strongly alkaline solutions with Na
`meta.borate.
`3. Strongly acid solutions with the boron (B) halides.
`
`These physiochemical properties may lead to differences in toxico(cid:173)
`logical response.
`For comparative purposes, dose levels of borates have been expressed
`in terms of B equivalents based on the fraction of B on a mol-wt basis. To
`obtain the equivalent dose of B, a dose of boric acid is multiplied by 0.175,
`whereas a dose of borax is multiplied by 0.113. These conversion factors
`are important, since some studies express dose in terms of B, whereas
`other studies express the dose in units of boric acid or borax. The B
`equivalents used are a generic designation rather than a designation of
`the element B.
`
`Biological Trace Element Research
`
`Vol. 66, 1998
`
`CFAD v. Anacor, IPR2015-01776, CFAD EXHIBIT 1054 - Page 9 of 22
`
`

`
`Hubbard
`
`Comparative Toxicology of Borates
`
`345
`
`)so Values
`Reference
`
`21, 22
`24
`
`21
`23
`25
`
`30
`
`26
`27
`
`32 reviewed
`in 2
`
`28
`28
`
`29
`
`31
`32
`
`have been evalu-
`
`unantly as undis-
`1logical pH, lead(cid:173)
`ta of mammals is
`;iochemical prop(cid:173)
`as:
`1erborate.
`lS with Na
`
`!es.
`
`rences in toxico-
`
`e been expressed
`mol-wt basis. To
`tltiplied by 0.175,
`inversion factors
`lS of B, whereas
`:>r borax. The B
`a designation of
`
`TOXICOKINETICS
`
`Toxicokinetics has been reviewed elsewhere (6). Studies have gener(cid:173)
`ally been carried out on boric acid as a representative inorganic borate.
`The toxicokinetics of boric acid and other hydrated forms of Na borates
`are very similar in animals and humans. Borates are readily absorbed
`orally in humans and animals (7-11); are not metabolized in either ani(cid:173)
`mals or humans; are excreted via the urine with a reported half-life <12 h
`in rats (12) and an estimated mean plasma half-life of 13.4 h in humans,
`with >94% of B excreted in the urine over a 96-h period (13,14). Borates
`are poorly absorbed through intact skin in both humans (15-17) and
`animals (7,18), and although they can be absorbed through damaged
`skin, absorption is dependent on the carrier (19,20).
`
`ACUTE TOXICITY
`
`The borates are in general of low acute oral toxicity in mammals,
`including rats and mice. An accidental poisoning case in cows and a
`further study in goats do not suggest that these species are more sen(cid:173)
`sitive to the effects of borates with respect to acute toxicity (34,35). The
`LDsos of those borates tested are shown in Table 1. For most borates,
`LDsos range from 2000 to 5000 mg /kg. The study design, in particular
`fixed-dose studies (dose fixed at 2000 mg/kg), does not allow a closer
`definition of the actual LDso (21-23). The LD5o for Zn borate 2.3.3.5 and
`Zn borate 4.1.1 is 10,000 mg/kg and >5000 mg/kg, respectively (31,32).
`The lower LD50 for Na perborate monohydrate ( <2000 mg/kg) may
`reflect gastrointestinal irritancy and generation of H20 2 (33). No signifi(cid:173)
`cant differences in acute oral toxicity were seen in mice and dogs in the
`limited studies available, although dogs exhibit an emetic effect in
`response to high doses of borates. The main symptoms of toxicity seen
`in all species tested were central nervous system (CNS) depression,
`ataxia, and convulsions.
`Humans do not seem to be any more sensitive than other mammals
`with respect to acute toxicity, although it is difficult to make a good
`quantitative judgment (36). Lethal dose figures of 15-20 g of boric acid
`have generally been cited in the literature, but there are very few actual
`acute cases reported and the basis for these figures is unclear. In contrast,
`of 784 more recent reports of accidental ingestions, none were reported
`as fatal and 88.3% were asymptomatic. The estimated dose range was
`10 mg to 88.8 g (14). However, a single intake of 30 g of boric acid was fatal
`in one case (37). Symptoms of acute effects may include nausea, vomit(cid:173)
`ing, gastric discomfort, skin flushing, excitation, convulsions, depression,
`and vascular collapse. Other data come from multiple exposures. In two
`infants, symptoms of irritability, vomiting, diarrhea, and erythema were
`observed, with no lasting effects (38).
`
`Vol. 66, 1998
`
`Biological Trace Element Research
`
`Vol. 66, 1998
`
`CFAD v. Anacor, IPR2015-01776, CFAD EXHIBIT 1054 - Page 10 of 22
`
`

`
`346
`
`Hubbard
`
`Low acute inhalation toxicity was observed in those borates tested.
`The 4-h LC50 is >2 mg/m3 for boric acid, borax, disodium tetraborate
`pentahydrate, and disodium octaborate tetrahydrate and >4.95 mg/m3
`for Zn borate 4.1.1 (39-43). By contrast, B halides have high acute
`inhalation toxicity owing to the formation of hydrochloric or hydroflu(cid:173)
`oric acid in aqueous medium (44,45). As would be expected owing to
`the low skin absorption, the acute dermal toxicity was low for those
`borates tested (LD50 > 10 g/kg for Zn borate 2.3.3.5; >2 g/kg for Zn
`borate 4.1.1, boric acid, boric oxide, disodium octaborate, Na tetrabo(cid:173)
`rate anhydrous, and pentaborate, and >1 g/kg for Na tetraborate deca(cid:173)
`hydrate) (45-50).
`Boric acid and borax are used at concentrations of 5% in cosmetics
`in the US and in talc in Europe, up to 3% in other cosmetics in Europe,
`and up to 0.5% in oral hygiene products in Europe and elsewhere (16,51).
`As expected, generally inorganic borates are not skin irritants or are very
`mild irritants (23,52-59). Although Na metaborates are very alkaline in
`solution (0.1 % is ~ pH 10.0), an irritancy study indicated that there was
`no skin irritancy associated with Na metaborate tetrahydrate (57). This
`may be owing to its low alkaline reserve, which would prevent the pro(cid:173)
`duction of a high pH in contact with the skin.
`Evidence for eye irritation is less clear and probably reflects differ(cid:173)
`ences in physiochemical properties. Boric acid is not an eye irritant in
`rabbits, nor are disodium octaborate tetrahydrate and Zn borates
`(16,60-64). Severe eye irritation was observed in rabbit studies with
`borax and disodium tetrabornte pentahydrate, whereas moderate irrita(cid:173)
`tion was seen with Na perborate monohydrate and tetrahydrate
`(33,65-67). Boric oxide is also a mild eye irritant. The Na metaborates
`are likely to be eye irritants owing to their alkalinity, but the low alka(cid:173)
`line reserve is likely to reduce the severity of this effect. However, in
`50 years of occupational exposure to Na tetraborates, no significant
`adverse effects on the human eye have been observed. Rabbit eye stud(cid:173)
`ies are known to overestimate human eye hazard. Boric acid and borax
`are used at up to 5% in eye washes in the US, a concentration approach(cid:173)
`ing a saturated solution (16).
`No borate tested has displayed skin sensitization (2,68-73). No evi(cid:173)
`dence of skin sensitization has been seen in humans exposed occupa(cid:173)
`tionally to Na borates or in a human patch test with a 3% aqueous boric
`acid solution (73,74).
`A study of workers exposed occupationally to Na borates up to lev(cid:173)
`els of 14 mg Na borates/m3 (the nuisance dust level is 10 mg/m3) indi(cid:173)
`cated no significant respiratory effects (i.e., nose, eye, and throat
`irritation). No significant difference in response was found between
`workers exposed to different types of Na borate dusts. No effect on pul(cid:173)
`monary function or other health effects were observed in workers
`exposed chronically to borates (75).
`
`Biological Trace Element Research
`
`Vol. 66, 1998
`
`CFAD v. Anacor, IPR2015-01776, CFAD EXHIBIT 1054 - Page 11 of 22
`
`

`
`Hubbard
`
`Comparative Toxicology of Borates
`
`347
`
`10se borates tested.
`sodium tetraborate
`·and >4.95 mg/m3
`:; have high acute
`hloric or hydroflu(cid:173)
`expected owing to
`was low for those
`5; >2 g/kg for Zn
`1orate, Na tetrabo(cid:173)
`:i tetraborate deca-
`
`Jf 5% in cosmetics
`smetics in Europe,
`. elsewhere (16,51).
`:ritants or are very
`·e very alkaline in
`ted that there was
`hydrate (57). This
`:l prevent the pro-
`
`bly reflects differ(cid:173)
`an eye irritant in
`and Zn borates
`Jbit studies with
`s moderate irrita(cid:173)
`md tetrahydrate
`! Na metaborates
`but the low alka(cid:173)
`:ect. However, in
`·s, no significant
`Rabbit eye stud(cid:173)
`c acid and borax
`ration approach-
`
`2,68-73). No evi(cid:173)
`exposed occupa(cid:173)
`% aqueous boric
`
`orates up to lev-
`10 mg/m3) indi(cid:173)
`~ye, and throat
`found between
`Jo effect on pul(cid:173)
`red in workers
`
`MOTAGENICITY AND CARCINOGENICITY
`
`A number of in vitro mutagenicity studies, including bacterial muta(cid:173)
`tion assays in Salmonella typhimurium and Escherichia coli, gene mutation
`in mammalian cells (L5178Y mouse lymphoma, V79 Chinese hamster
`cells, C3H/10Tl/2 cells), bacterial DNA-damage assay, unscheduled
`DNA synthesis (hepatocytes), chromosomal aberration, and sister chro(cid:173)
`matid exchange in mammalian cell (Chinese hamster ovary, CHO cells),
`have been carried out on boric acid, borax, or disodium octaborate
`tetrahydrate. No evidence of mutagenic activity was observed (76-80). In
`addition, no mutagenic activity was seen in vivo in a mouse bone mar(cid:173)
`row micronucleus study on boric acid (81). For Na perborate tetra(cid:173)
`hydrate, a weakly positive response in S. typhimurium in the absence of
`a metabolizing system was most likely owing to the production of H20:u
`a well-known phenomenon. This effect disappeared in the presence of a
`metabolizing system (82,83). Zn borates were negative in S. typhimurium
`(84,85), but Zn borate 4.1.1 was weakly mutagenic in a chromosome aber(cid:173)
`ration study in Chinese hamster lung (CHL) cells consistent with there
`being a high bioavailable Zn dose in the in vitro system (86). The weight
`of evidence supports a conclusion that Zn is not genotoxic in vivo, but
`the nature of some salts leads to greater bioavailability in in vitro systems
`allowing Zn to exert an effect on the genetic material on the cell (87). Inor(cid:173)
`ganic borates are not mutagenic in vitro with the exception of Zn borate
`4.1.1 and Na perborates, but all inorga~ic borates tested are not muta(cid:173)
`genic in vivo.
`
`SOBCHRONIC AND CHRONIC TOXICITY
`STUDIES
`
`A number of studies in which rats were fed boric acid or borax in
`their diet or drinking water for periods of 70-90 d indicated that the main
`target organ for toxicity was the testis. In addition to testicular atrophy,
`animals receiving doses of 88 mg B /kg body wt/ d for 90 d in their diet
`exhibited weight loss and, at higher doses, rapid respiration, inflamed
`eyes, swollen paws, and desquamation of the skin on the paws (21,76).
`In long-term feeding studies on boric acid and borax in both rats and
`dogs, no carcinogenic effects were observed (21). Also in a US National
`Toxicology Program (NIP) bioassay in mice, no carcinogenic effects were
`observed at doses of boric acid of 75 mg B/kg body wt/d and 200 mg
`B/kg body wt/d (76).
`.
`.
`In these studies, testicular effects were noted that are discussed m
`more detail below. In humans, multiple exposure results in various
`symptoms that may appear singly or together, and include dermatitis,
`alopecia, loss of appetite, nausea, vomiting, diarrhea, and focal or gener-
`
`Vol. 66, 1998
`
`Biological Trace Element Research
`
`Vol. 66, 1998
`
`CFAD v. Anacor, IPR2015-01776, CFAD EXHIBIT 1054 - Page 12 of 22
`
`

`
`348
`
`Hubbard
`
`alized CNS irritation or convulsions. Much data come from the mid-
`1800s to around 1940, when boric acid and borax were used systemati(cid:173)
`cally for a variety of medical conditions, including amenorrhea, malaria,
`epilepsy, urinary tract infection, and exudative pleuritis (88). In infants,
`similar symptoms were observed in babies given a honey-borax mixture
`on pacifiers (89, 90). Daily oral doses in adults ranged from 1 to 14 g/ d.
`Repeated doses in the 6-10 g/ d range were given for as long as several
`weeks. Reduction of dose to 1 g/ d in one case resulted in the symptoms
`disappearing. In all cases, withdrawal of treatment resulted in recovery
`from effects with no sequelae observed. Very few deaths were recorded by
`Kliegel, and those that occurred may have been owing to the underlying
`medical problem or to the combination of

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket